FDA Approves Lenvatinib (Lenvima) for Liver Cancer FDA Approves Lenvatinib (Lenvima) for Liver Cancer
The oral therapy lenvatinib joins sorafenib as the only drugs approved for first-line treatment of patients with unresectable hepatocellular carcinoma.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news
More News: Cancer | Cancer & Oncology | Carcinoma | Health | Hematology | Hepatocellular Carcinoma | Liver | Liver Cancer | Oral Cancer | Urology & Nephrology